Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Europe
Europe
Gilead expects big increase in Europeans treated with hep C drug
Yahoo/Reuters
Wed, 02/11/15 - 09:50 am
Gilead Sciences
Europe
hepatitis C
Sovaldi
Harvoni
Gilead faces challenge to European patent on pricey hep C drug
Yahoo/Reuters
Tue, 02/10/15 - 10:21 am
Gilead Sciences
Europe
patents
hepatitis C
Sovaldi
Orexigen Provides Progress Update on Mysimba European Marketing Authorization
Yahoo
Mon, 02/9/15 - 06:16 pm
Orexigen
Europe
Mysimba
Contrave
Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Drug Discovery and Development
Mon, 01/26/15 - 09:42 am
Aprea
Europe
ovarian cancer
APR-246
EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’
WSJ Pharmalot
Fri, 01/23/15 - 10:31 am
EMA
Europe
EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis
First Word Pharma
Mon, 01/19/15 - 12:02 pm
Boehringer Ingelheim
Ofev
IPF
idiopathic pulmonary fibrosis
Europe
AbbVie’s hepatitis C drug gets European approval for sale
Marketwatch
Fri, 01/16/15 - 08:45 am
AbbVie
hepatitis C
Europe
Viekira Pak
Celgene: European Decision Not Best Case Scenario, Not Worst Case Either
Barron's
Fri, 12/19/14 - 04:03 pm
Celgene
Europe
Revlimid
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Orexigen
obesity
Contrave
Europe
Mysimba
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Yahoo/Reuters
Thu, 12/18/14 - 09:01 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
Celgene Hits 52-Week High on Positive CHMP Opinion
Yahoo/Zacks.com
Mon, 12/1/14 - 07:31 pm
Celgene
CHMP
Europe
Otezla
Novartis says heart-failure drug wins faster review in Europe
Yahoo/Reuters
Sat, 11/29/14 - 10:30 am
Novartis
heart failure
Europe
LCZ696
Once-weekly Lilly diabetes drug wins EU approval
Yahoo/Reuters
Tue, 11/25/14 - 03:19 pm
Eli Lilly
diabetes
Europe
Trulicity
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
TheStreet.com
Tue, 11/18/14 - 10:59 am
Gilead Sciences
Harvoni
Europe
hepatitis C
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tue, 11/18/14 - 10:06 am
Orexigen
Europe
Contrave
obesity
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
TheStreet.com
Mon, 11/10/14 - 04:08 pm
Orexigen
Contrave
Europe
Glaxo files regulatory submissions for asthma drug candidate
Seeking Alpha
Wed, 11/5/14 - 09:31 am
GSK
asthma
Europe
mepolizumab
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Fri, 10/24/14 - 07:31 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
AstraZeneca looks to EU decision for next cancer drug boost
Yahoo/Reuters
Tue, 10/14/14 - 09:48 am
AstraZeneca
Europe
olaparib
ovarian cancer
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »